May. 8 at 5:58 PM
LifeVantage (LFVN) beat EPS expectations in F3Q25 with
$0.26 vs.
$0.19 est., up 23.8% Y/Y, driven by strong demand for its MindBody GLP-1 System.
🔹 Revenue rose 21.1% to
$58.4M, slightly below forecast
🔹 Customer count dipped post-launch, but consultant retention held steady
🔹 Adjusted EBITDA of
$6.4M beat expectations, boosted by lower incentives
🔹 International MindBody rollout began in March, expected to drive F4Q growth
Subscribe at our website to follow along with Doug Lane!
https://www.watertowerresearch.com/doc?docID=UR_LFVN_05072025
$LFVN